JP2004189753A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004189753A5 JP2004189753A5 JP2004062679A JP2004062679A JP2004189753A5 JP 2004189753 A5 JP2004189753 A5 JP 2004189753A5 JP 2004062679 A JP2004062679 A JP 2004062679A JP 2004062679 A JP2004062679 A JP 2004062679A JP 2004189753 A5 JP2004189753 A5 JP 2004189753A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- fatty acid
- acid esters
- mono
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 49
- 235000014113 dietary fatty acids Nutrition 0.000 claims 26
- 239000000194 fatty acid Substances 0.000 claims 26
- 229930195729 fatty acid Natural products 0.000 claims 26
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 24
- -1 fatty acid esters Chemical class 0.000 claims 22
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 17
- 108010036949 Cyclosporine Proteins 0.000 claims 17
- 229960001265 ciclosporin Drugs 0.000 claims 17
- 229930182912 cyclosporin Natural products 0.000 claims 16
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 14
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims 14
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims 12
- 239000001069 triethyl citrate Substances 0.000 claims 12
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims 12
- 235000013769 triethyl citrate Nutrition 0.000 claims 12
- 150000004665 fatty acids Chemical class 0.000 claims 11
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 11
- 239000004094 surface-active agent Substances 0.000 claims 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 10
- 229930105110 Cyclosporin A Natural products 0.000 claims 8
- 235000013773 glyceryl triacetate Nutrition 0.000 claims 7
- 239000004615 ingredient Substances 0.000 claims 7
- 229960002622 triacetin Drugs 0.000 claims 7
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 claims 7
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims 6
- 239000002202 Polyethylene glycol Substances 0.000 claims 6
- 239000000839 emulsion Substances 0.000 claims 6
- 239000004530 micro-emulsion Substances 0.000 claims 6
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 6
- 150000001298 alcohols Chemical class 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 229920005862 polyol Polymers 0.000 claims 5
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 235000006708 antioxidants Nutrition 0.000 claims 3
- 239000004064 cosurfactant Substances 0.000 claims 3
- 239000011732 tocopherol Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims 2
- 206010052779 Transplant rejections Diseases 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims 2
- 230000001363 autoimmune Effects 0.000 claims 2
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 2
- 230000004968 inflammatory condition Effects 0.000 claims 2
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 2
- 150000003138 primary alcohols Chemical class 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 229960001295 tocopherol Drugs 0.000 claims 2
- 229930003799 tocopherol Natural products 0.000 claims 2
- 150000003626 triacylglycerols Chemical class 0.000 claims 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 2
- 239000008158 vegetable oil Substances 0.000 claims 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 150000002191 fatty alcohols Chemical class 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 230000036457 multidrug resistance Effects 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims 1
- 235000010384 tocopherol Nutrition 0.000 claims 1
- 235000019149 tocopherols Nutrition 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9804742.6A GB9804742D0 (en) | 1998-03-06 | 1998-03-06 | Organic compounds |
| GBGB9805104.8A GB9805104D0 (en) | 1998-03-10 | 1998-03-10 | Organic compounds |
| GBGB9805199.8A GB9805199D0 (en) | 1998-03-11 | 1998-03-11 | Organic compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000534187A Division JP2002505271A (ja) | 1998-03-06 | 1999-03-04 | サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004189753A JP2004189753A (ja) | 2004-07-08 |
| JP2004189753A5 true JP2004189753A5 (cg-RX-API-DMAC7.html) | 2009-04-23 |
Family
ID=27269231
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000534187A Withdrawn JP2002505271A (ja) | 1998-03-06 | 1999-03-04 | サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物 |
| JP2004062679A Pending JP2004189753A (ja) | 1998-03-06 | 2004-03-05 | サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000534187A Withdrawn JP2002505271A (ja) | 1998-03-06 | 1999-03-04 | サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物 |
Country Status (29)
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858401A (en) | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
| JP2002531515A (ja) * | 1998-12-11 | 2002-09-24 | ファーマソリューションズ・インコーポレイテッド | 水に難溶性の薬剤のための自己乳化組成物 |
| DK1154759T3 (da) * | 1998-12-30 | 2008-12-08 | Dexcel Ltd | Dispergerbart koncentrat til indgift af cyclosporin |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
| AU2127400A (en) * | 1999-11-02 | 2001-05-14 | Cipla Limited | A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof |
| GB2362573A (en) * | 2000-05-25 | 2001-11-28 | Cipla Ltd | Cyclosporin formulation |
| AU1043201A (en) * | 1999-11-02 | 2001-05-14 | Cipla Limited | Cyclosporin formulation |
| GB0008785D0 (en) * | 2000-04-10 | 2000-05-31 | Novartis Ag | Organic compounds |
| DE10024451A1 (de) * | 2000-05-18 | 2001-11-29 | Asta Medica Ag | Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung |
| WO2003002095A1 (fr) * | 2001-06-28 | 2003-01-09 | Chugai Seiyaku Kabushiki Kaisha | Preparation d'une micro-emulsion de type huile-eau |
| US6960563B2 (en) | 2001-08-31 | 2005-11-01 | Morton Grove Pharmaceuticals, Inc. | Spontaneous emulsions containing cyclosporine |
| GB2391471B (en) * | 2002-08-02 | 2005-05-04 | Satishchandra Punambhai Patel | Pharmaceutical compositions |
| KR20040047056A (ko) * | 2002-11-29 | 2004-06-05 | 한미약품 주식회사 | 비페닐디메틸디카복실레이트의 경구용 마이크로에멀젼조성물 |
| US8802116B2 (en) | 2003-02-27 | 2014-08-12 | Novasel Australia Pty. Ltd. | Poloxamer emulsion preparations |
| KR20040084240A (ko) * | 2003-03-27 | 2004-10-06 | (주) 코스메디 | 고형지질나노입자, 이를 함유하는 활성성분 전달용약학조성물 및 이의 제조방법 |
| US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
| JP2008518931A (ja) * | 2004-10-29 | 2008-06-05 | ノバルティス アクチエンゲゼルシャフト | 自発的に分散可能な医薬組成物 |
| MX2007011250A (es) * | 2005-03-21 | 2007-11-14 | Ivax Pharmaceuticals Sro | Inhibidor de la cristalizacion y su uso en capsulas de gelatina. |
| CN101032620B (zh) * | 2007-03-08 | 2010-05-19 | 上海凯昭医药科技有限公司 | 一种环孢素自乳化制剂及其制备方法 |
| US20090130198A1 (en) * | 2007-11-21 | 2009-05-21 | Innopharmax Inc. | Pharmaceutical composition with enhanced bioavailability |
| AU2009226019C1 (en) | 2008-03-20 | 2014-02-20 | Virun, Inc. | Emulsions including a PEG-derivative of tocopherol |
| CN102036661B (zh) | 2008-03-20 | 2016-12-28 | 维尔恩公司 | 维生素衍生物及其用途 |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| JP5567909B2 (ja) * | 2010-06-17 | 2014-08-06 | 東洋カプセル株式会社 | タクロリムス含有カプセル剤 |
| US8741373B2 (en) | 2010-06-21 | 2014-06-03 | Virun, Inc. | Compositions containing non-polar compounds |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
| JP5717034B2 (ja) * | 2012-08-27 | 2015-05-13 | 丸和バイオケミカル株式会社 | マクロライド系化合物を含有する土壌線虫防除用薬剤 |
| US20150374835A1 (en) | 2012-12-31 | 2015-12-31 | Jrx Biotechnology, Inc. | Liquid topical pharmaceutical nano-emulsion formulations |
| KR101458466B1 (ko) * | 2013-06-24 | 2014-11-07 | 한국화학연구원 | 면역억제제가 봉입된 마이셀을 함유하는 경구제 |
| WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
| US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| CN108024914A (zh) | 2015-09-17 | 2018-05-11 | Jrx生物技术有限公司 | 改善皮肤的水合作用或润湿作用的方法 |
| WO2018098501A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| WO2020018974A1 (en) | 2018-07-20 | 2020-01-23 | Lipocine Inc. | Liver disease |
| SI3886813T1 (sl) * | 2018-11-26 | 2023-05-31 | Hepion Pharmaceuticals, Inc. | Farmacevtske formulacije analogov ciklosporina |
| WO2024014958A2 (en) * | 2022-07-15 | 2024-01-18 | Seranovo Holding B.V. | Lides formulation platform |
| WO2024014959A2 (en) * | 2022-07-15 | 2024-01-18 | Seranovo Holding B.V. | Micelle-generating formulations with improved hydrophobicity |
| CN117797093A (zh) * | 2024-02-29 | 2024-04-02 | 中国农业科学院农业环境与可持续发展研究所 | 一种以大环内酯类药物为活性成分的兽用口服纳米液体制剂 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8903804D0 (en) * | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5639724A (en) * | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
| JP2632010B2 (ja) * | 1988-01-29 | 1997-07-16 | 三共株式会社 | シクロスポリン製剤 |
| KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| EP1142568A1 (en) * | 1992-09-25 | 2001-10-10 | Novartis AG | Pharmaceutical compositions containing cyclosporins |
| GB2278780B (en) * | 1993-05-27 | 1998-10-14 | Sandoz Ltd | Macrolide formulations |
| DE4322826A1 (de) * | 1993-07-08 | 1995-01-12 | Galenik Labor Freiburg Gmbh | Pharmazeutisches Präparat |
| WO1995022343A1 (en) * | 1994-02-17 | 1995-08-24 | Shiseido Company, Ltd. | Cyclosporin-containing emulsion composition |
| JP3131112B2 (ja) * | 1994-02-17 | 2001-01-31 | 株式会社資生堂 | シクロスポリン含有乳化組成物 |
| DK0786986T3 (da) * | 1994-10-26 | 2002-04-29 | Novartis Ag | Anvendelse af en umættet fedtalkohol |
| IL129547A (en) * | 1994-10-26 | 2001-01-11 | Novartis Ag | Pharmaceutical compositions comprising a macrolide and an acid |
| HU215966B (hu) * | 1994-11-21 | 1999-07-28 | BIOGAL Gyógyszergyár Rt. | Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum |
| KR970064620A (ko) * | 1996-03-05 | 1997-10-13 | 임성기 | 사이클로스포린-함유 외용약제 조성물 |
| KR980008239A (ko) * | 1996-07-26 | 1998-04-30 | 김충환 | 사이클로스포린-함유 약학적 조성물 |
| US6063762A (en) * | 1997-12-05 | 2000-05-16 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
| DE69842121D1 (de) * | 1997-12-10 | 2011-03-17 | Cyclosporine Therapeutics Ltd | Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen |
-
1998
- 1998-10-16 ID IDW20001708A patent/ID25908A/id unknown
-
1999
- 1999-03-04 FR FR9902748A patent/FR2775596B1/fr not_active Expired - Fee Related
- 1999-03-04 HU HU0101080A patent/HUP0101080A3/hu unknown
- 1999-03-04 EP EP03013016A patent/EP1354582A3/en not_active Withdrawn
- 1999-03-04 DE DE19983012T patent/DE19983012T1/de not_active Withdrawn
- 1999-03-04 CA CA002322845A patent/CA2322845C/en not_active Expired - Fee Related
- 1999-03-04 CZ CZ20003222A patent/CZ301967B6/cs not_active IP Right Cessation
- 1999-03-04 BR BR9908597-6A patent/BR9908597A/pt not_active IP Right Cessation
- 1999-03-04 IL IL13824899A patent/IL138248A0/xx active IP Right Grant
- 1999-03-04 PE PE1999000178A patent/PE20000324A1/es not_active Application Discontinuation
- 1999-03-04 GB GB0021495A patent/GB2350791B/en not_active Expired - Fee Related
- 1999-03-04 WO PCT/EP1999/001415 patent/WO1999044584A1/en not_active Ceased
- 1999-03-04 SK SK1319-2000A patent/SK285139B6/sk not_active IP Right Cessation
- 1999-03-04 AT AT99908952T patent/ATE277599T1/de active
- 1999-03-04 AR ARP990100910A patent/AR015729A1/es not_active Application Discontinuation
- 1999-03-04 CN CNB99803746XA patent/CN1195495C/zh not_active Expired - Fee Related
- 1999-03-04 JP JP2000534187A patent/JP2002505271A/ja not_active Withdrawn
- 1999-03-04 EP EP99908952A patent/EP1059913B1/en not_active Revoked
- 1999-03-04 PT PT99908952T patent/PT1059913E/pt unknown
- 1999-03-04 ES ES99908952T patent/ES2228014T3/es not_active Expired - Lifetime
- 1999-03-04 BE BE9900153A patent/BE1012400A5/fr not_active IP Right Cessation
- 1999-03-04 DE DE69920668T patent/DE69920668T2/de not_active Expired - Lifetime
- 1999-03-04 KR KR10-2000-7009861A patent/KR100443306B1/ko not_active Expired - Fee Related
- 1999-03-04 NZ NZ506644A patent/NZ506644A/xx not_active IP Right Cessation
- 1999-03-04 TR TR2000/02586T patent/TR200002586T2/xx unknown
- 1999-03-04 AU AU28361/99A patent/AU749217B2/en not_active Ceased
- 1999-03-05 CO CO99013726A patent/CO4930289A1/es unknown
- 1999-03-05 MY MYPI99000807A patent/MY129274A/en unknown
- 1999-03-05 IT IT1999MI000452A patent/IT1313550B1/it active
- 1999-05-21 TW TW094129536A patent/TWI257870B/zh not_active IP Right Cessation
- 1999-05-21 TW TW093120909A patent/TWI248368B/zh not_active IP Right Cessation
- 1999-05-21 TW TW088107417A patent/TWI236912B/zh not_active IP Right Cessation
- 1999-11-09 BE BE9900732A patent/BE1013423A5/fr not_active IP Right Cessation
-
2000
- 2000-08-18 BE BE2000/0520A patent/BE1013648A5/fr not_active IP Right Cessation
- 2000-08-29 NO NO20004299A patent/NO331800B1/no not_active IP Right Cessation
- 2000-09-05 IL IL138248A patent/IL138248A/en not_active IP Right Cessation
- 2000-10-25 FR FR0013782A patent/FR2800277B1/fr not_active Expired - Fee Related
-
2004
- 2004-03-05 JP JP2004062679A patent/JP2004189753A/ja active Pending
- 2004-03-26 FR FR0403163A patent/FR2853546B1/fr not_active Expired - Fee Related
-
2006
- 2006-01-05 FR FR0600097A patent/FR2881956A1/fr not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004189753A5 (cg-RX-API-DMAC7.html) | ||
| RU2143919C1 (ru) | Фармацевтическая композиция, продукт трансэтерификации кукурузного масла глицерином и способ его получения | |
| KR0167696B1 (ko) | 사이클로스포린-함유 연질캅셀제 조성물 | |
| RU2257917C2 (ru) | Самоэмульгирующиеся композиции для плохорастворимых в воде лекарственных препаратов | |
| CA2322845A1 (en) | Emulsion preconcentrates containing cyclosporin or a macrolide | |
| DE60019100T2 (de) | Im wesentlichen ölfreie cyclosporin zusammensetzungen | |
| RU2246296C2 (ru) | Композиция, включающая ундеканоат тестостерона и касторовое масло | |
| TWI240636B (en) | Spontaneously dispersible pharmaceutical containing n-benzoyl-staurosporine and the use thereof | |
| HU225535B1 (en) | Microemulsion pre-concentrate and microemulsion | |
| KR20030066781A (ko) | 친지성 유효성분을 포함하는 미셀 콜로이드상의 약제학적조성물 | |
| CZ301382B6 (cs) | Hydrofilní binární systémy pro podávání cyklosporinu | |
| KR101025641B1 (ko) | 매스틱 자가유화에멀젼 조성물 및 이를 함유하는 캡슐 | |
| HUP0202737A2 (hu) | Lipáz inhibítorokat tartalmazó diszperziós készítmények | |
| JP2005513096A (ja) | シクロスポリン、親水性界面活性剤及び親油性界面活性剤を含んで成る医薬組成物 | |
| JPH11100326A (ja) | 軟質ゼラチンカプセル剤 | |
| KR20000016761A (ko) | 사이클로스포린-함유 연질캅셀제 | |
| US20100035949A1 (en) | Microemulsion dosage forms of valsartan and methods of making the same | |
| KR20050083607A (ko) | 시클로스포린을 포함하는 경구용 약학적 조성물 | |
| KR101928589B1 (ko) | 알리스포리비르를 포함하는 제약 조성물 | |
| JP2007509136A (ja) | ビフェニルジメチルジカルボキシレート及びシリビンを含む経口用マイクロエマルション組成物 | |
| AU741923B2 (en) | Pharmaceutical compositions | |
| KR100525234B1 (ko) | 사이클로스포린 함유 연질캅셀제 및 그 제조방법 | |
| RU2000125560A (ru) | Предварительно приготовленные эмульсионные концентраты, содержащие циклоспорин или макролид | |
| JP2005075804A (ja) | メナテトレノン含有医薬組成物 | |
| AT409082B (de) | Pharmazeutische orale zusammensetzung enthaltend fk506 |